Table of contents

  • Preliminary material
    • Title and verso page
    • Contents
    • Acknowledgments
    • Abbreviations
    • Symbols
    • Summary
      • Prostate cancer is the leading cancer among males
      • Mortality is decreasing
      • Survival is high, and improving
      • Prostate cancer presents an economic burden
      • There are differences between population groups and internationally
  • Body section
    • 1 Introduction
      • Overview
      • The prostate
      • Prostate cancer
      • Characteristics
      • Risk factors
    • 2 Detection, diagnosis and management
      • Key findings
      • Detection and diagnosis
      • Prostate-specific antigen testing
      • Digital rectal examination
      • Biopsy of the prostate
      • Management and treatment
      • No initial treatment, active surveillance
      • Active treatment
      • Palliative care
    • 3 Incidence
      • Key findings
      • Overview
      • Age comparison
      • Time trend
      • Projected incidence to 2020
    • 4 Mortality
      • Key findings
      • Overview
      • Age comparison
      • Time trend
      • The influence of incidence on mortality
      • Projected mortality to 2020
    • 5 Survival
      • Key findings
      • Overview
      • Age comparison
      • Time trend
    • 6 Expenditure on prostate cancer
      • Key findings
      • Overview
      • Age comparison
      • Time trend
    • 7 Population groups
      • Key findings
      • Overview
      • State and territory
      • Aboriginal and Torres Strait Islander status
      • Remoteness area
      • Socioeconomic disadvantage
      • Country of birth
    • 8 International comparisons
      • Key findings
      • Overview
      • Incidence
      • Mortality
      • Mortality-to-incidence ratio
  • End matter
    • Appendix 1 Technical information
      • Classifications
      • Health classifications
      • Area-based classifications
      • Data sources and limitations
      • AIHW data sources
      • External data sources
      • Data limitations
      • Statistical methods
      • Age-specific rates
      • Age-standardisation
      • Incidence
      • Prevalence
      • Risk to age 45, 55, 65, 75 or 85
      • Survival
      • Technical notes
      • Defining prostate cancer-related hospitalisations
      • Interpreting comparison data
    • References
    • List of tables
    • List of figures
    • List of boxes
    • Related publications